Evidence map›Paper›PMID 36290840›Full record

SynthesisCurrent oncology (Toronto, Ont.)2022

Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience.

Michihide Maeda, Tsuyoshi Hisa, Hiroki Kurahashi, Harue Hayashida, Misooja Lee, Reisa Kakubari, Shinya Matsuzaki, Seiji Mabuchi, Shoji Kamiura

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Michihide MaedaDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Tsuyoshi HisaDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Hiroki KurahashiDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Harue HayashidaDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Misooja LeeDepartment of Forensic Medicine, School of Medicine, Kindai University, Osaka 589-8511, Japan.
Reisa KakubariDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Shinya MatsuzakiDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.ORCID 0000-0001-5725-9994
Seiji MabuchiDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Shoji KamiuraDepartment of Gynecology, Osaka International Cancer Institute, Osaka 541-8567, Japan.ORCID 0000-0002-5723-8891
Osaka International Cancer Institute · JPKindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In early-stage cervical cancer, ovarian metastasis is relatively rare, and ovarian transposition is often performed during surgery. Although rare, the diagnosis and surgical approach for recurrence at transposed ovaries are challenging. This study focused on the diagnosis and surgical management of transposed ovarian recurrence in cervical cancer patients. A 45-year-old premenopausal woman underwent radical hysterectomy, bilateral salpingectomy, and pelvic lymphadenectomy following postoperative concurrent chemoradiotherapy for stage IB1 cervical cancer. During the initial surgery, the ovary was transposed to the paracolic gutter, and no postoperative complications were observed. Ovarian recurrence was diagnosed using positron emission tomography-computed tomography, and a laparoscopic bilateral oophorectomy was performed. A systematic review identified nine women with transposed ovarian recurrence with no other metastases of cervical cancer, and no studies have discussed the optimal surveillance of transposed ovaries. Of those (n = 9), four women had died of the disease within 2 years of the second surgery, and the prognosis of transposed ovarian cervical cancer seemed poor. Nevertheless, three women underwent laparoscopic oophorectomies, none of whom experienced recurrence after the second surgery. Few studies have examined the surgical management of transposed ovarian recurrence. The optimal surgical approach for transposed ovarian recurrence of cervical cancer requires further investigation.

Indexed as

Ovarian NeoplasmsUterine Cervical NeoplasmsFemaleHumansHysterectomyMiddle AgedPelviscervical cancerlaparoscopic resectionovarian metastasisovarian transposition

Identifiers

PMID36290840
PMCPMC9600108
OpenAlexW4297504261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.